{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2026-01-28T12:29:42.275345+00:00",
  "news": [
    {
      "title": "Why Vertex (VRTX) Is Up 8.0% After Analyst Upgrades Spotlight Its CF Strength And Kidney Pipeline - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Why Vertex (VRTX) Is Up 8.0% After Analyst Upgrades Spotlight Its CF Strength And Kidney Pipeline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2026-01-27T21:19:34+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "A Look At Vertex Pharmaceuticals (VRTX) Valuation After Recent Analyst Upgrades And CASGEVY Approval - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxOaWFXd2FTNmg2b01naEt4SzUyckdCbHl6a2JmZXFUS3pTUDdheVhKYzUxRnhQR0NiNlZCY0ZOSlR1TVBYRXlMdXNpR0VzWmRSYVJDd2NzTTVtcUtWdXFyb0lqdmRTNnVXUTBBX1g2UVJSVEhoekxsaWpjTjNJMjhQWkM1S2g3TDE4Vmh0SUNtRURuQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxOaWFXd2FTNmg2b01naEt4SzUyckdCbHl6a2JmZXFUS3pTUDdheVhKYzUxRnhQR0NiNlZCY0ZOSlR1TVBYRXlMdXNpR0VzWmRSYVJDd2NzTTVtcUtWdXFyb0lqdmRTNnVXUTBBX1g2UVJSVEhoekxsaWpjTjNJMjhQWkM1S2g3TDE4Vmh0SUNtRURuQQ?oc=5\" target=\"_blank\">A Look At Vertex Pharmaceuticals (VRTX) Valuation After Recent Analyst Upgrades And CASGEVY Approval</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-01-25T02:08:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Barlow Wealth Partners Inc. Sells 21,078 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNNklnTUtORVVMSHA3cDRQM01WTTBicXNMQXZyT0JTNWRqdDYyVFczdHpiNk50Zkp2akhJNWVLUUIzLTlkODQtY2JaZENHVDFGM29GVGNxd3JPaWdXcTl5aENwTDdGcXJ1VWZMREt4OG9IT24ydXJ0eGo1QktaMDhVVnVYaGVSXzA4NUJFbnhBVXY4OEFVU0JOd1NiUDZITDVlVlRuVTk2d2VGQjFTcFRjdjRYYjVlblBtYWJoLUpzellaYmdmbWhlR1FlaURxUzJfUHNUVWNoRzZrQ1JYQkE0MEE2d04?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5AFBVV95cUxNNklnTUtORVVMSHA3cDRQM01WTTBicXNMQXZyT0JTNWRqdDYyVFczdHpiNk50Zkp2akhJNWVLUUIzLTlkODQtY2JaZENHVDFGM29GVGNxd3JPaWdXcTl5aENwTDdGcXJ1VWZMREt4OG9IT24ydXJ0eGo1QktaMDhVVnVYaGVSXzA4NUJFbnhBVXY4OEFVU0JOd1NiUDZITDVlVlRuVTk2d2VGQjFTcFRjdjRYYjVlblBtYWJoLUpzellaYmdmbWhlR1FlaURxUzJfUHNUVWNoRzZrQ1JYQkE0MEE2d04?oc=5\" target=\"_blank\">Barlow Wealth Partners Inc. Sells 21,078 Shares of Vertex Pharmaceuticals Incorporated $VRTX</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2026-01-27T08:50:40+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Working at Vertex - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5\" target=\"_blank\">Working at Vertex</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-06-02T15:34:51+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "RBC Capital Upgrades Vertex Pharmaceuticals (VRTX) - Nasdaq",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPM1NESC1OalIxRDF6WmMxVldPaGVRQ3FPRk9USmc5MkdvTGNwdHNDVnZ5cXhvcEhsVDdJYXpKZEk5MzNGbGF4bW5Yb2p2cTBWdnpzV0JCVjRVQjBYMGZIVGREZmRVSUlDeER1dEVMaTA0ekdOZkxVX3dlVjloZlF4TWJJSUhZLVU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxPM1NESC1OalIxRDF6WmMxVldPaGVRQ3FPRk9USmc5MkdvTGNwdHNDVnZ5cXhvcEhsVDdJYXpKZEk5MzNGbGF4bW5Yb2p2cTBWdnpzV0JCVjRVQjBYMGZIVGREZmRVSUlDeER1dEVMaTA0ekdOZkxVX3dlVjloZlF4TWJJSUhZLVU?oc=5\" target=\"_blank\">RBC Capital Upgrades Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
      "published": "2026-01-23T00:02:00+00:00",
      "source": "Nasdaq"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX) Sees Price Target Increase by UBS to $545 | VRTX Stock News - GuruFocus",
      "link": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxORmhGaXpWOE9mcGg2LXUwYmVmTVNTNDM0bDZlU2dPYzZFa0d3bmxsMG9RMVpDbVZHYXhoYmprYmlhREhBQnQ3WmFzMzhib1RmT1FhSVBrcF8tbkNZOTdXVmJfRmMzOG5ha1U5LWR5TTNhU2pmOGsxWUpUdDVoaFVkSUhmbldhcl9mNUZNdkV1S0dEbTFrNGk4OUNHalU2dy1VZjViZjlHeUd0dF92MDkwaGt3WkExX2I4Tl9SVi1uUWFqZDVKQ3Yza2NuSDhzOXRS?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0AFBVV95cUxORmhGaXpWOE9mcGg2LXUwYmVmTVNTNDM0bDZlU2dPYzZFa0d3bmxsMG9RMVpDbVZHYXhoYmprYmlhREhBQnQ3WmFzMzhib1RmT1FhSVBrcF8tbkNZOTdXVmJfRmMzOG5ha1U5LWR5TTNhU2pmOGsxWUpUdDVoaFVkSUhmbldhcl9mNUZNdkV1S0dEbTFrNGk4OUNHalU2dy1VZjViZjlHeUd0dF92MDkwaGt3WkExX2I4Tl9SVi1uUWFqZDVKQ3Yza2NuSDhzOXRS?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Sees Price Target Increase by UBS to $545 | VRTX Stock News</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GuruFocus</font>",
      "published": "2026-01-26T18:37:25+00:00",
      "source": "GuruFocus"
    },
    {
      "title": "Breaking Down Vertex Pharmaceuticals: 12 Analysts Share Their Views - Benzinga",
      "link": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNOTBPUERHS2g4emhZcVdtWjFBQmUzRE9ERURDdHZWQTlYSEQtQktXMVMzRVNqNGwxWE5BeGJBdWttU1lYOG1JTWxMSEdfZlctYXBYMTVhS1FfNUhwX3NyQTRQVDBBYzRaYm5uMUFBaFVmcVIxaVJQNEUxVS1oZW96QndaWTF3Y0NJVU55aTROWEtkcHBNNjkwWDFzajRxSndJb1NnZWY1TmVJNzRNOHZxRWRBY1VhVjI1WDJFdzdYS19vLTdmWWR4T3FBaw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiywFBVV95cUxNOTBPUERHS2g4emhZcVdtWjFBQmUzRE9ERURDdHZWQTlYSEQtQktXMVMzRVNqNGwxWE5BeGJBdWttU1lYOG1JTWxMSEdfZlctYXBYMTVhS1FfNUhwX3NyQTRQVDBBYzRaYm5uMUFBaFVmcVIxaVJQNEUxVS1oZW96QndaWTF3Y0NJVU55aTROWEtkcHBNNjkwWDFzajRxSndJb1NnZWY1TmVJNzRNOHZxRWRBY1VhVjI1WDJFdzdYS19vLTdmWWR4T3FBaw?oc=5\" target=\"_blank\">Breaking Down Vertex Pharmaceuticals: 12 Analysts Share Their Views</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>",
      "published": "2026-01-23T19:01:03+00:00",
      "source": "Benzinga"
    },
    {
      "title": "Vertex Pharmaceuticals: Prepared To Defend Their Dominance And Expand Their Expertise - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPNjFaUkd0ODNBWW9SelU0Y0NtQ3JDT1NhZlRVSmsybURHRXBNLW5jbEt4NVNBbHVDbzNQQ0dNdUE4ZHBTMG4tV3o3UVNzaDZoNzhlQ1pvc1BpX01icUgwX1ZsSkd0bUFrUUpRRUh3SDRJakFOcG9KZHppc0U2X0FZLXYxdTFxRTFpX21TWHdzd1pyNk9RRk1yUUFKaUlXZ3U0MEtIdWFCbkdXd1E0OFgweHladHEzeFBQTUlV?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPNjFaUkd0ODNBWW9SelU0Y0NtQ3JDT1NhZlRVSmsybURHRXBNLW5jbEt4NVNBbHVDbzNQQ0dNdUE4ZHBTMG4tV3o3UVNzaDZoNzhlQ1pvc1BpX01icUgwX1ZsSkd0bUFrUUpRRUh3SDRJakFOcG9KZHppc0U2X0FZLXYxdTFxRTFpX21TWHdzd1pyNk9RRk1yUUFKaUlXZ3U0MEtIdWFCbkdXd1E0OFgweHladHEzeFBQTUlV?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Prepared To Defend Their Dominance And Expand Their Expertise</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-12-30T08:00:00+00:00",
      "source": "Seeking Alpha"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex’s New Products Dim as Analysts Eye Kidney Portfolio - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5\" target=\"_blank\">Vertex’s New Products Dim as Analysts Eye Kidney Portfolio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2026-01-27",
      "close": 474.1700134277344
    },
    "history": [
      {
        "date": "2026-01-16",
        "close": 441.3599853515625
      },
      {
        "date": "2026-01-20",
        "close": 442.0799865722656
      },
      {
        "date": "2026-01-21",
        "close": 461.1400146484375
      },
      {
        "date": "2026-01-22",
        "close": 467.3500061035156
      },
      {
        "date": "2026-01-23",
        "close": 468.4100036621094
      },
      {
        "date": "2026-01-26",
        "close": 476.8399963378906
      },
      {
        "date": "2026-01-27",
        "close": 474.1700134277344
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}